239 related articles for article (PubMed ID: 31126146)
1. c-Cbl: An Important Regulator and a Target in Angiogenesis and Tumorigenesis.
Lyle CL; Belghasem M; Chitalia VC
Cells; 2019 May; 8(5):. PubMed ID: 31126146
[TBL] [Abstract][Full Text] [Related]
2. A critical role for the E3-ligase activity of c-Cbl in VEGFR-2-mediated PLCgamma1 activation and angiogenesis.
Singh AJ; Meyer RD; Navruzbekov G; Shelke R; Duan L; Band H; Leeman SE; Rahimi N
Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5413-8. PubMed ID: 17372230
[TBL] [Abstract][Full Text] [Related]
3. c-Cbl, a ubiquitin E3 ligase that targets active β-catenin: a novel layer of Wnt signaling regulation.
Chitalia V; Shivanna S; Martorell J; Meyer R; Edelman E; Rahimi N
J Biol Chem; 2013 Aug; 288(32):23505-17. PubMed ID: 23744067
[TBL] [Abstract][Full Text] [Related]
4. The c-Cbl ubiquitin ligase regulates nuclear β-catenin and angiogenesis by its tyrosine phosphorylation mediated through the Wnt signaling pathway.
Shivanna S; Harrold I; Shashar M; Meyer R; Kiang C; Francis J; Zhao Q; Feng H; Edelman ER; Rahimi N; Chitalia VC
J Biol Chem; 2015 May; 290(20):12537-46. PubMed ID: 25784557
[TBL] [Abstract][Full Text] [Related]
5. c-Cbl inhibits angiogenesis and tumor growth by suppressing activation of PLCγ1.
Meyer RD; Husain D; Rahimi N
Oncogene; 2011 May; 30(19):2198-206. PubMed ID: 21242968
[TBL] [Abstract][Full Text] [Related]
6. A role for protein ubiquitination in VEGFR-2 signalling and angiogenesis.
Rahimi N
Biochem Soc Trans; 2009 Dec; 37(Pt 6):1189-92. PubMed ID: 19909244
[TBL] [Abstract][Full Text] [Related]
7. Role of c-Cbl-dependent regulation of phospholipase Cgamma1 activation in experimental choroidal neovascularization.
Husain D; Meyer RD; Mehta M; Pfeifer WM; Chou E; Navruzbekov G; Ahmed E; Rahimi N
Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6803-9. PubMed ID: 20592236
[TBL] [Abstract][Full Text] [Related]
8. c-Cbl Expression Correlates with Human Colorectal Cancer Survival and Its Wnt/β-Catenin Suppressor Function Is Regulated by Tyr371 Phosphorylation.
Kumaradevan S; Lee SY; Richards S; Lyle C; Zhao Q; Tapan U; Jiangliu Y; Ghumman S; Walker J; Belghasem M; Arinze N; Kuhnen A; Weinberg J; Francis J; Hartshorn K; Kolachalama VB; Cifuentes D; Rahimi N; Chitalia VC
Am J Pathol; 2018 Aug; 188(8):1921-1933. PubMed ID: 30029779
[TBL] [Abstract][Full Text] [Related]
9. Targeting the E3 ubiquitin casitas B-lineage lymphoma decreases osteosarcoma cell growth and survival and reduces tumorigenesis.
Sévère N; Dieudonné FX; Marty C; Modrowski D; Patiño-García A; Lecanda F; Fromigué O; Marie PJ
J Bone Miner Res; 2012 Oct; 27(10):2108-17. PubMed ID: 22623369
[TBL] [Abstract][Full Text] [Related]
10. c-Cbl-mediated neddylation antagonizes ubiquitination and degradation of the TGF-β type II receptor.
Zuo W; Huang F; Chiang YJ; Li M; Du J; Ding Y; Zhang T; Lee HW; Jeong LS; Chen Y; Deng H; Feng XH; Luo S; Gao C; Chen YG
Mol Cell; 2013 Feb; 49(3):499-510. PubMed ID: 23290524
[TBL] [Abstract][Full Text] [Related]
11. c-Cbl-mediated ubiquitination of IRF3 negatively regulates IFN-β production and cellular antiviral response.
Zhao X; Zhu H; Yu J; Li H; Ge J; Chen W
Cell Signal; 2016 Nov; 28(11):1683-93. PubMed ID: 27503123
[TBL] [Abstract][Full Text] [Related]
12. Binding of Cbl to a phospholipase Cgamma1-docking site on platelet-derived growth factor receptor beta provides a dual mechanism of negative regulation.
Reddi AL; Ying G; Duan L; Chen G; Dimri M; Douillard P; Druker BJ; Naramura M; Band V; Band H
J Biol Chem; 2007 Oct; 282(40):29336-47. PubMed ID: 17620338
[TBL] [Abstract][Full Text] [Related]
13. Balancing Protein Stability and Activity in Cancer: A New Approach for Identifying Driver Mutations Affecting CBL Ubiquitin Ligase Activation.
Li M; Kales SC; Ma K; Shoemaker BA; Crespo-Barreto J; Cangelosi AL; Lipkowitz S; Panchenko AR
Cancer Res; 2016 Feb; 76(3):561-71. PubMed ID: 26676746
[TBL] [Abstract][Full Text] [Related]
14. δ-Catenin Increases the Stability of EGFR by Decreasing c-Cbl Interaction and Enhances EGFR/Erk1/2 Signaling in Prostate Cancer.
Shrestha N; Shrestha H; Ryu T; Kim H; Simkhada S; Cho YC; Park SY; Cho S; Lee KY; Lee JH; Kim K
Mol Cells; 2018 Apr; 41(4):320-330. PubMed ID: 29629558
[TBL] [Abstract][Full Text] [Related]
15. Cbl-family ubiquitin ligases and their recruitment of CIN85 are largely dispensable for epidermal growth factor receptor endocytosis.
Ahmad G; Mohapatra BC; Schulte NA; Nadeau SA; Luan H; Zutshi N; Tom E; Ortega-Cava C; Tu C; Sanada M; Ogawa S; Toews ML; Band V; Band H
Int J Biochem Cell Biol; 2014 Dec; 57():123-34. PubMed ID: 25449262
[TBL] [Abstract][Full Text] [Related]
16. Cbl-independent degradation of Met: ways to avoid agonism of bivalent Met-targeting antibody.
Lee JM; Kim B; Lee SB; Jeong Y; Oh YM; Song YJ; Jung S; Choi J; Lee S; Cheong KH; Kim DU; Park HW; Han YK; Kim GW; Choi H; Song PH; Kim KA
Oncogene; 2014 Jan; 33(1):34-43. PubMed ID: 23208509
[TBL] [Abstract][Full Text] [Related]
17. CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF-β signaling.
Kang JM; Park S; Kim SJ; Hong HY; Jeong J; Kim HS; Kim SJ
Oncogene; 2012 Dec; 31(50):5123-31. PubMed ID: 22310290
[TBL] [Abstract][Full Text] [Related]
18. CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies.
Lv K; Jiang J; Donaghy R; Riling CR; Cheng Y; Chandra V; Rozenova K; An W; Mohapatra BC; Goetz BT; Pillai V; Han X; Todd EA; Jeschke GR; Langdon WY; Kumar S; Hexner EO; Band H; Tong W
Genes Dev; 2017 May; 31(10):1007-1023. PubMed ID: 28611190
[TBL] [Abstract][Full Text] [Related]
19. Identification of c-Cbl as a new ligase for insulin-like growth factor-I receptor with distinct roles from Mdm2 in receptor ubiquitination and endocytosis.
Sehat B; Andersson S; Girnita L; Larsson O
Cancer Res; 2008 Jul; 68(14):5669-77. PubMed ID: 18632619
[TBL] [Abstract][Full Text] [Related]
20. c-Cbl is involved in Met signaling in B cells and mediates hepatocyte growth factor-induced receptor ubiquitination.
Taher TE; Tjin EP; Beuling EA; Borst J; Spaargaren M; Pals ST
J Immunol; 2002 Oct; 169(7):3793-800. PubMed ID: 12244174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
